{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:58:30Z","timestamp":1771667910895,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.diabres.2022.109857","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T18:42:14Z","timestamp":1648320134000},"page":"109857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial"],"prefix":"10.1016","volume":"186","author":[{"given":"Nancy Samir","family":"Elbarbary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Abdel Rahman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Atef","family":"Ghallab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/07853890.2016.1222449","article-title":"Is there a role for gut microbiota in type 1 diabetes pathogenesis?","volume":"49","author":"Bibb\u00f2","year":"2017","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-13-108","article-title":"Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial","volume":"13","author":"Anderson","year":"2013","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.diabres.2022.109857_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-09-0167","article-title":"Hypoglycemic agent, insulin resistance and cardio-vascular disease in patients with type 2 diabetes","volume":"161","author":"Hemmingsen","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"7-8","key":"10.1016\/j.diabres.2022.109857_b0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.20452\/pamw.3527","article-title":"Association between adjunctive metformin therapy in young type 1 diabetes patients with excess body fat and reduction of carotid intima-media thickness","volume":"126","author":"Burchardt","year":"2016","journal-title":"Pol Arch Med Wewn"},{"issue":"12","key":"10.1016\/j.diabres.2022.109857_b0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nm.3713","article-title":"The brown fat- enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2022.109857_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12916-016-0703-6","article-title":"Association of circulating neuregulin4 with metabolic syndrome in obese adults: a cross-sectional study","volume":"14","author":"Cai","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.diabres.2022.109857_b0035","doi-asserted-by":"crossref","first-page":"26242","DOI":"10.1038\/srep26242","article-title":"Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.109857_b0040","first-page":"1038","article-title":"Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders","volume":"10","author":"Yan","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"12","key":"10.1016\/j.diabres.2022.109857_b0045","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.metabol.2015.08.013","article-title":"A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease","volume":"64","author":"Dai","year":"2015","journal-title":"Metabolism"},{"issue":"16","key":"10.1016\/j.diabres.2022.109857_b0050","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0055","article-title":"Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.109857_b0060","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2022.109857_b0065","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes-2020. Diabetes Care 2020 ;43:S14-S31.","DOI":"10.2337\/dc20-S002"},{"key":"10.1016\/j.diabres.2022.109857_b0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2337\/diacare.26.1.138","article-title":"Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial","volume":"26","author":"Hamilton","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2022.109857_b0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1442-200x.2005.02075.x","article-title":"Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus","volume":"47","author":"Urakami","year":"2005","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/db16-0915","article-title":"Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission","volume":"66","author":"Wang","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdiacomp.2005.11.002","article-title":"Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes","volume":"21","author":"Weintrob","year":"2007","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.diabres.2022.109857_b0100","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diacare.27.2007.S79","article-title":"American Diabetes Association. Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2014.12.029","article-title":"Intima media thickness measurement in children: A statement from the Association for European Paediatric Cardiology (AEPC) Working Group on Cardiovascular Prevention endorsed by the Association for European Paediatric Cardiology","volume":"238","author":"Dalla Pozza","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.diabres.2022.109857_b0110","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/13510002.2017.1301624","article-title":"Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in \u03b2-thalassemia major","volume":"22","author":"Adly","year":"2017","journal-title":"Redox Rep"},{"issue":"10","key":"10.1016\/j.diabres.2022.109857_b0115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.20452\/pamw.1925","article-title":"Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low-density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study","volume":"123","author":"Burchardt","year":"2013","journal-title":"Pol Arch Med Wewn"},{"issue":"14","key":"10.1016\/j.diabres.2022.109857_b0120","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/01.CIR.0000124725.46165.2C","article-title":"Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes","volume":"109","author":"J\u00e4rvisalo","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.diabres.2022.109857_b0125","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2337\/dc14-0700","article-title":"AdDIT Study Group. Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)","volume":"37","author":"Maftei","year":"2014","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2022.109857_b0130","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1210\/jc.2017-00781","article-title":"Effect of Metformin on Vascular Function in Children With Type 1 Diabetes: A 12-Month Randomized Controlled Trial","volume":"102","author":"Anderson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.109857_b0135","article-title":"The clinical application of metformin in children and adolescents: A short update","volume":"91","author":"Soliman","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.diabres.2022.109857_b0140","first-page":"1","article-title":"The effect of metformin on adolescents with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"2016","author":"Liu","year":"2016","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamapediatrics.2013.4200","article-title":"Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger","volume":"168","author":"McDonagh","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.diabres.2022.109857_b0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/dia.2014.0190","article-title":"Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis","volume":"17","author":"Liu","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.diabres.2022.109857_b0160","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-009-1636-9","article-title":"The use of metformin in type 1 diabetes: a systematic review of efficacy","volume":"53","author":"Vella","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109857_b0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1530\/eje.0.1490323","article-title":"Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity","volume":"149","author":"S\u00e4rnblad","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2022.109857_b0170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/pedi.12140","article-title":"Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study","volume":"16","author":"Nadeau","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2022.109857_b0175","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.metop.2021.100080","article-title":"The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents","volume":"9","author":"Sikorskaya","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.diabres.2022.109857_b0180","first-page":"79","article-title":"Metformin and placebo therapy in adjunct with lifestyle intervention both improve weight loss and insulin resistance in obese adolescents","volume":"97","author":"Hawkins","year":"2011","journal-title":"Arch Dis Child"},{"issue":"21","key":"10.1016\/j.diabres.2022.109857_b0185","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1001\/jama.2015.16174","article-title":"Effect of Metformin Added to Insulin on Glycemic Control Among Overweight\/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial","volume":"314","author":"Libman","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","article-title":"Metformin: Mechanisms in Human Obesity and Weight Loss","volume":"8","author":"Yerevanian","year":"2019","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.diabres.2022.109857_b0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12933-018-0738-4","article-title":"Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy","volume":"17","author":"van Stee","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2022.109857_b0200","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/ijms19102863","article-title":"Metformin: An Old Drug with New Applications","volume":"19","author":"Zhou","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.diabres.2022.109857_b0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10557-008-6092-0","article-title":"Metformin: effects on micro and macrovascular complications in type 2 diabetes","volume":"22","author":"Bailey","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"issue":"23-24","key":"10.1016\/j.diabres.2022.109857_b0215","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.cca.2010.08.038","article-title":"Mechanisms of LDL oxidation","volume":"411","author":"Yoshida","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.diabres.2022.109857_b0220","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.2337\/db10-0862","article-title":"Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes","volume":"59","author":"Secrest","year":"2010","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.diabres.2022.109857_b0225","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00125-017-4337-9","article-title":"Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes","volume":"60","author":"Griffin","year":"2017","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.diabres.2022.109857_b0230","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s11606-017-4061-7","article-title":"Shifting Paradigms in the Medical Management of Type 2 Diabetes: Reflections on Recent Cardiovascular Outcome Trials","volume":"32","author":"Ismail-Beigi","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"15","key":"10.1016\/j.diabres.2022.109857_b0235","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.diabres.2022.109857_b0240","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001202","article-title":"Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis","volume":"3","author":"Forouzandeh","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.diabres.2022.109857_b0245","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s13300-018-0435-z","article-title":"The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A. Case-Control Study","volume":"9","author":"Hu","year":"2018","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0250","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/pedi.12252","article-title":"Achieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetes","volume":"16","author":"Bjornstad","year":"2015","journal-title":"Pediatr Diabetes"},{"issue":"11","key":"10.1016\/j.diabres.2022.109857_b0255","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.2337\/dc13-0631","article-title":"Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes","volume":"36","author":"Bjornstad","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0260","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/dme.12572","article-title":"Estimated insulin sensitivity predicts regression of albuminuria in type 1 diabetes","volume":"32","author":"Bjornstad","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.109857_b0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4239\/wjd.v6.i1.8","article-title":"Insulin sensitivity and complications in type 1 diabetes: new insights","volume":"6","author":"Bjornstad","year":"2015","journal-title":"World J Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2022.109857_b0270","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jdiacomp.2016.02.011","article-title":"Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study","volume":"30","author":"Bjornstad","year":"2016","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0275","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2009-1756","article-title":"Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function","volume":"95","author":"Nadeau","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0280","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/dc14-1742","article-title":"Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes","volume":"38","author":"Bjornstad","year":"2015","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.diabres.2022.109857_b0285","doi-asserted-by":"crossref","first-page":"e3247","DOI":"10.1097\/MD.0000000000003247","article-title":"Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial","volume":"95","author":"Pan","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.diabres.2022.109857_b0290","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1096\/fj.201800529RR","article-title":"Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity","volume":"33","author":"Polianskyte-Prause","year":"2019","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.diabres.2022.109857_b0295","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/ph13120452","article-title":"Metformin Protects against Podocyte Injury in Diabetic Kidney Disease","volume":"13","author":"Lehtonen","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.diabres.2022.109857_b0300","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12020-017-1324-3","article-title":"Circulating neuregulin 4 concentrations in patients with newly diagnosed type 2 diabetes: a cross-sectional study","volume":"57","author":"Zhang","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.diabres.2022.109857_b0305","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20139","article-title":"Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus","volume":"149","author":"Kocak","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"12","key":"10.1016\/j.diabres.2022.109857_b0310","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00592-017-1044-4","article-title":"Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study","volume":"54","author":"Yan","year":"2017","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2022.109857_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1536\/ihj.18-654","article-title":"Neuregulin-4, an Adipokine, as a Residual Risk Factor of Atherosclerotic Coronary Artery Disease","volume":"60","author":"Sato","year":"2019","journal-title":"Int Heart J"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:23Z","timestamp":1759173803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722006696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":63,"alternative-id":["S0168822722006696"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109857","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109857"}}